← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Radiomedix, Inc.
Houston, TX
$4,442,013
Total funding
4
Grants
Funding over time
peak $2M · FY2014–22$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,442,013 · 4
By mechanism
R44$1,999,943 · 1
N01$1,994,002 · 1
N43$298,132 · 1
R43$149,936 · 1
Investigators at Radiomedix, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
IGF::OT::IGFNCI SBIR Phase II Topic 346: Molecularly Targeted Radiation Therapy for Cancer TreatmentTitle: Targeted Radionuclide Therapy of Neuroendocrine Tumors using 212Pb-octreotate Analogs$1,994,002
N01 · FY2018 · CA
Targeted alpha-emitter therapy of patients with PRRT refractory neuroendocrine tumors$1,451,761
R44 · FY2022 · CA
Targeted alpha-emitter therapy of patients with PRRT refractory neuroendocrine tumors$548,182
R44 · FY2021 · CA
IGF::OT::IGF TARGETED RADIONUCLIDE THERAPY OF NEUROENDOCRINE TUMORS USING PB212-OCTREOTATE ANALOGS$298,132
N43 · FY2016 · CA
Targeted Theranostics for Metastatic Melanoma$149,936
R43 · FY2014 · CA